<DOC>
	<DOCNO>NCT02109497</DOCNO>
	<brief_summary>This study design determine pharmacokinetic ( PK ) profile single oral dose caffeine effect PBT2 metabolism caffeine healthy volunteer .</brief_summary>
	<brief_title>Phase 1 Study Determine Effects PBT2 Pharmacokinetic Profile Caffeine</brief_title>
	<detailed_description>This study conduct participant receive dose caffeine 100 mg Day 1 follow 7 day washout period commence 5 consecutive day PBT2 250 mg Day 8 12 second dose caffeine 100 mg Day 12 . Pharmacokinetic sample collect dose study drug , along safety monitoring assessment .</detailed_description>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Healthy male female BMI 19 30kg/m2 No clinically significant abnormality Exposure medications/drugs interfere metabolism PBT2 include drug inhibit induce CYP1A2 Use caffeinecontaining beverage , supplement alcohol Significant history depression psychiatric illness Surgical medical condition could significantly alter drug absorption , distribution , metabolism excretion Unable swallow capsule tablet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>